Otolaryngology · Sheffield, AL
NPI
1790985133
Since 2007
Specialty
Otolaryngology
Code 207Y00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
421 Cox Blvd
Sheffield, AL, 35660
Phone (256) 386-7040
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
5,355 services
Medicare patients, 2024
624
Average age 76
Drug cost, 2024
$104K
2,529 prescriptions
Company payments, 2025
$376
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Francis A Long Jr. was code 95165 (treatment - miscellaneous), 1,260 times for 33 patients. In total Francis A Long Jr. billed 5,355 services in 86 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 1,260 | 33 | $9.40 | $12K |
| 95115 Treatment - Miscellaneous | Office | 1,160 | 30 | $6.28 | $7,290 |
| 99213 Office E&M - Established | Office | 718 | 396 | $58.05 | $42K |
| 92550 Test - Miscellaneous | Office | 281 | 241 | $14.18 | $3,984 |
| 99203 Office E&M - New | Office | 201 | 201 | $64.56 | $13K |
| 92587 Test - Miscellaneous | Office | 179 | 159 | $13.61 | $2,437 |
| 92504 E&M - Miscellaneous | Office | 165 | 128 | $17.68 | $2,917 |
| 70210 Standard X-ray | Office | 103 | 56 | $19.48 | $2,006 |
| 99204 Office E&M - New | Office | 79 | 79 | $112.67 | $8,901 |
| 92552 Vision, Hearing, and Speech Services | Office | 71 | 64 | $24.64 | $1,749 |
| 99214 Office E&M - Established | Office | 71 | 58 | $88.80 | $6,305 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 66 | 14 | $0.08 | $5.03 |
| 70220 Standard X-ray | Office | 64 | 63 | $21.61 | $1,383 |
| 31575 Other Organ Systems | Office | 63 | 37 | $84.32 | $5,312 |
| 17250 Destruction Skin Lesion | Office | 35 | 14 | $28.59 | $1,001 |
By year: 2022 $155K for 5,730 services; 2023 $141K for 5,550 services; 2024 $133K for 5,355 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 21 | 19 | $8.65 | $182 |
| 82540 Clinical Chemistry | 13 | 13 | $4.55 | $59.15 |
| 84520 Clinical Chemistry | 13 | 13 | $3.87 | $50.31 |
Medicare prescription drug claims, 2024
In 2024, the drug Francis A Long Jr. prescribed most often to Medicare patients was Levocetirizine Dihydrochloride, with 452 prescriptions and refills. In total Francis A Long Jr. wrote 2,529 Medicare prescriptions that cost $104K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levocetirizine Dihydrochloride Generic | 452 | 718 | 210 | $4,394 |
| Fluticasone Propionate Generic | 436 | 628 | 227 | $6,324 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 130 | 130 | 101 | $1,373 |
| Montelukast Sodium Generic | 128 | 283 | 57 | $1,097 |
| Methylprednisolone Generic | 112 | 112 | 96 | $910 |
| Esomeprazole Magnesium Generic | 91 | 175 | 47 | $5,809 |
| Ipratropium Bromide Generic | 88 | 113 | 42 | $3,209 |
| Azelastine Hcl Generic | 81 | 103 | 40 | $2,264 |
| Desloratadine Generic | 80 | 115 | 29 | $3,267 |
| Ciprofloxacin Hcl Generic | 77 | 77 | 57 | $353 |
| Cefprozil Generic | 76 | 76 | 57 | $2,693 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 70 | 70 | 53 | $1,042 |
| Cimetidine Generic | 62 | 119 | 40 | $2,077 |
| Clindamycin Hcl Generic | 61 | 61 | 47 | $724 |
| Naproxen Generic | 60 | 62 | 40 | $268 |
Brand drugs: 38 claims; generic drugs: 2,491 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Francis A Long Jr. $376 ($376 in general payments such as food, travel and fees) from 6 companies. The largest payer was Inspire Medical Systems, Inc. with $174.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.